Recent advances and developments in COVID‐19 in the context of allergic diseases-Reference-Cited by-同舟云学术

Recent advances and developments in COVID‐19 in the context of allergic diseases

Published:2021-09 Issue:7 Volume:11 Page:
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clinical and Translational Allergy

Author:

Ding Mei¹²^ORCID,Dong Xiang¹²^ORCID,Sun Yuan‐li¹²,Sokolowska Milena³⁴^ORCID,Akdis Mübeccel³^ORCID,Veen Willem³^ORCID,Azkur Ahmet Kursat⁵^ORCID,Azkur Dilek⁶^ORCID,Akdis Cezmi A.³⁴^ORCID,Gao Ya‐dong¹²^ORCID

Affiliation:

1. Department of Allergology Zhongnan Hospital of Wuhan University Wuhan China

2. Hubei Province Key Laboratory of Allergy and Immunology Wuhan University Wuhan China

3. Swiss Institute of Allergy and Asthma Research (SIAF) University of Zurich Davos Switzerland

4. Christine Kühne ‐ Center for Allergy Research and Education (CK‐CARE) Davos Switzerland

5. Department of Virology Faculty of Veterinary Medicine University of Kirikkale Kirikkale Turkey

6. Division of Pediatric Allergy and Immunology Department of Pediatrics Faculty of Medicine University of Kirikkale Kirikkale Turkey

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clt2.12065

Reference138 articles.

1. Asthma and COVID‐19: Is asthma a risk factor for severe outcomes?

2. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

3. Is asthma protective against COVID‐19?

4. Asthmatic patients and COVID‐19: Different disease course?

5. Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID‐19

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allergic diseases aggravate the symptoms of SARS-CoV-2 infection in China;Frontiers in Immunology;2023-12-22

2. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023;International Forum of Allergy & Rhinology;2023-03-06

3. Omalizumab may protect allergic patients against COVID-19: A systematic review;World Allergy Organization Journal;2023-02

4. Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [ComirnatyⓇ]);International Journal of Infectious Diseases;2022-11

5. Update on pathomechanisms and treatments in allergic rhinitis;Allergy;2022-08-04